Quarterly report · Q2
7459.TEDINET S100S94Y
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.78T | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥3.36T | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.69T | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥20.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥25.5bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥29.3bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥65.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥33.3bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥32.8bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥33.3bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥17.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥38.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥17.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥22.5bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥21.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥1.82T | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥1.71T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.74T | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.10T | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.02T | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥714.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥688.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥674.7bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥209.1bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥195.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥207.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥193.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥238.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥260.4bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥31.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥9.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥10.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥39.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥12.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥43.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥80.48 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.08 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥184.82 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.51 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.13 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥179.12 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥77.56 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 32.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥1.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥37m |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥56.8bn |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥56.8bn |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1m |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥583.4bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥583.3bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥146m |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13.8bn |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.14T |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.14T |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥1.78T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥1.78T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥20.7bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥2.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | ¥191m |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥36.8bn |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.8bn |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1m |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥554.9bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥554.7bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥174m |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥12.0bn |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.10T |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.09T |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.69T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.69T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥25.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 508
| Item | Context | Value | Unit |
|---|---|---|---|
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -74000000 | JPY |
| Current assets | Prior1YearInstant | 1179280000000 | JPY |
| Current assets | CurrentQuarterInstant | 1259152000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 103478000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 100103000000 | JPY |
| Land | Prior1YearInstant | 121157000000 | JPY |
| Land | CurrentQuarterInstant | 117984000000 | JPY |
| Other net ppe | Prior1YearInstant | 43727000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 56461000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 268363000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 274549000000 | JPY |
| Goodwill | Prior1YearInstant | 11903000000 | JPY |
| Goodwill | CurrentQuarterInstant | 12151000000 | JPY |
| Customer related intangible assets | Prior1YearInstant | 18914000000 | JPY |
| Customer related intangible assets | CurrentQuarterInstant | 18283000000 | JPY |
| Other ia | Prior1YearInstant | 9186000000 | JPY |
| Other ia | CurrentQuarterInstant | 9222000000 | JPY |
| Intangible assets | Prior1YearInstant | 40004000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 39656000000 | JPY |
| Investment securities | Prior1YearInstant | 192623000000 | JPY |
| Investment securities | CurrentQuarterInstant | 206634000000 | JPY |
| Other ioa | Prior1YearInstant | 30073000000 | JPY |
| Other ioa | CurrentQuarterInstant | 36458000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -687000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -670000000 | JPY |
| Investments and other assets | Prior1YearInstant | 222010000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 242422000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 530378000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 556628000000 | JPY |
| Assets | Prior1YearInstant | 1709658000000 | JPY |
| Assets | CurrentQuarterInstant | 1815781000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 890966000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 951513000000 | JPY |
| Income taxes payable | Prior1YearInstant | 12152000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 17230000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 7820000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 7411000000 | JPY |
| Provision for loss on anti monopoly act cl | Prior1YearInstant | 5704000000 | JPY |
| Provision for loss on anti monopoly act cl | CurrentQuarterInstant | 5704000000 | JPY |
| Other cl | Prior1YearInstant | 54875000000 | JPY |
| Other cl | CurrentQuarterInstant | 65477000000 | JPY |
| Current liabilities | Prior1YearInstant | 971519000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 1047336000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 16909000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 16989000000 | JPY |
| Other ncl | Prior1YearInstant | 33175000000 | JPY |
| Other ncl | CurrentQuarterInstant | 36838000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 50084000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 53827000000 | JPY |
| Liabilities | Prior1YearInstant | 1021603000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |